working

Sign in

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account

This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account


Sign In
Not a commercial user? Register here for our wider research bundle

More Content

More Content

Hybridan Monthly - February Edition

Companies: GTC STX N4P CGNR 1SN QUBE OBI RCFX

Hardman & Co Healthcare Index: 2025 – Index rose, but another tough year

Companies: GSK FUM IMM AGY GDR HVO FAB VAL STX

Morning Note – 30 January 2026

Companies: 88E LPA RUA TRT SEA STX CREO

Shield Therapeutics doubles Q2 revenue and sets sights on 2025 profitability with ACCRUFeR momentum

Companies: Shield Therapeutics Plc

Shield Therapeutics - China update: Submission, milestones, royalties

Companies: Shield Therapeutics Plc

© Research Tree 2026

  • Apple Store
  • Play Store

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top